Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecule expressed early in pregnancy may help patients tolerate transplants

15.10.2003


Transplant surgeon Oscar H. Grandas (left) and reproductive immunologist Anatolij Horuzsko are looking at a molecule expressed early in pregnancy that may provide a better way to help transplanted organs survive.



A molecule expressed in the earliest stages of pregnancy that vanishes when the baby is born seems to keep some cells responsible for directing the immune system in an immature and accepting stage, Medical College of Georgia researchers says.

Their finding that the molecule HLA-G helps make dendritic cells – which work like air-traffic controllers for the immune system – tolerant helps explain how a fetus, with genes from both parents, can avoid rejection by the mother’s immune system.

And it has them optimistic that the natural mechanism could be replicated to help preserve a transplanted heart or kidney.



"These immature dendritic cells can induce suppressor cells that will suppress the immune response," said Dr. Anatolij Horuzsko, reproductive immunologist. He is principal investigator on a $ 1.3 million grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health to explore whether this selective immune suppression – which occurs in the placenta where mother and developing baby touch – can help transplant patients avoid rejection without putting them at risk for new infection and disease.

Dr. Horuzsko and his co-investigator Dr. Oscar H. Grandas, transplant surgeon, say it’s a logical pursuit because a fetus is essentially a transplant in which, for nine months, a developing body containing genetically foreign material – the half he gets from his father – often escapes rejection by the mother’s immune system. It’s believed that some lost pregnancies result when, for some reason, localized suppression doesn’t happen.

Amazingly there is evidence that in some transplant patients natural suppression also occurs.

Some of the many questions Drs. Horuzsko and Grandas want to answer are, ’Is the spontaneous suppression mechanism that occurs in some patients the same one that occurs during pregnancy?’ and ’Can they make the suppression happen for all patients?’

Dr. Horuzsko has found that HLA-G binds with the inhibitory receptor on the surface of dendritic cells, leaving the cells, at least for a time, immature and tolerant. In research, published in 2002 in the European Journal of Immunology, he performed skin grafts on transgenic mice which express HLA-G and found some of the dendritic cells oddly changed and nonresponsive, a state which enabled the skin grafts to survive about a month longer than those on normal mice. The human equivalent likely would be much longer since a day in a mouse’s life translates to about a month for a human.

This mechanism provides a targeted escape from the usual rigorous patrol of the immune system. HLA-G is an antigen, which is a substance that gets the attention of the immune system; good antigen matches are desirable between an organ donor and transplant recipient because it reduces the risk of rejection. A fetus and a donated organ have much in common; both logically would be viewed by the immune system as foreign bodies that need elimination because both would have foreign antigens.

"From a transplant point of view, this is a huge problem that we have," Dr. Grandas said. "We don’t know who we need to immunosuppress," he said, referencing studies such as a recent one at the University of Pittsburgh that showed that as many as 70 percent of recipients don’t reject their transplanted organs even though they are on minimal immunosuppressive therapy. "What that is telling me is there are people who reject and people who do not and we don’t know why or how to tell who is who. Those are two big areas I have interest in. One is trying to identify the rejecters versus non-rejecters. The second is how can we modify human or animal dendritic cells in order to induce tolerance then wean transplant recipients from immunosuppression to see if we can prolong graft survival," Dr. Grandas said.

The ability to identify the best matches for patients has improved and the drugs patients take to avoid rejection have as well, Dr. Grandas said of the last 20 years in the transplant field. Ironically the net effect has been that acute rejection rates of grafts, or transplanted organs, have dramatically dropped but many organs are still failing over time.

"Even though the organ is not rejected, they are failing for other reasons," Dr. Grandas said. "Patients get infected and die with a working graft or they develop chronic graft dysfunction," because the drugs given to help the graft survive generally suppress the immune system, leaving patients more vulnerable to infection and disease.

So he collaborates with Dr. Horuzsko to test his findings about HLA-G and immature dendritic cells to see if they can create this scenario in animal models with the goal of eventually moving the work to patients.

In the lab, Dr. Grandas is doing islet cell transplants – which include the insulin-producing beta cells of the pancreas - to cure diabetes in rats. With his new NIH grant, Dr. Horusko is going to use HLA-G to modify the dendritic cells of the donor animal then inject them into the recipient rat before Dr. Grandas does the transplant.

Aware that there are likely other factors involved, he will also remove from the recipient some lymphocytes, cells of the immune system that already are programmed for cuing rejection. Transplant patients already get medication to do the same thing. "We will be giving a double whammy of lymphocytic depletion plus dendritic cell injection," said Dr. Horusko.

One of the many difficulties will be finding the optimal mechanism for inducing the desired, localized suppression. "I believe the future will be injection of a few cells to induce a specific mechanism to create only that and not touch anything else," Dr. Horuzsko said.

Dr. Grandas believes he is correct because patients would get donor-specific dendritic cells with the same antigen makeup as the organ they receive. "So you will have donor-specific induction of inhibitory cells," Dr. Grandas said.

"This is a goal because the patient needs to fight infection and, in this case, the immune system will be ready to do that and be tolerant of the transplant only," Dr. Horuzsko said.

The transplant surgeon noted that the approach other groups in the country are using is total bone marrow transplants in conjunction with organ transplants, which means replacing all components of the immune system plus components for blood production. "We think Dr. Horusko’s approach is a step ahead because you will infuse only a particular subset of cells that have the function we want regulated," Dr. Grandas said.

Toni Baker | EurekAlert!

More articles from Health and Medicine:

nachricht NIST scientists discover how to switch liver cancer cell growth from 2-D to 3-D structures
17.11.2017 | National Institute of Standards and Technology (NIST)

nachricht High speed video recording precisely measures blood cell velocity
15.11.2017 | ITMO University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

Im Focus: Novel Nano-CT device creates high-resolution 3D-X-rays of tiny velvet worm legs

Computer Tomography (CT) is a standard procedure in hospitals, but so far, the technology has not been suitable for imaging extremely small objects. In PNAS, a team from the Technical University of Munich (TUM) describes a Nano-CT device that creates three-dimensional x-ray images at resolutions up to 100 nanometers. The first test application: Together with colleagues from the University of Kassel and Helmholtz-Zentrum Geesthacht the researchers analyzed the locomotory system of a velvet worm.

During a CT analysis, the object under investigation is x-rayed and a detector measures the respective amount of radiation absorbed from various angles....

Im Focus: Researchers Develop Data Bus for Quantum Computer

The quantum world is fragile; error correction codes are needed to protect the information stored in a quantum object from the deteriorating effects of noise. Quantum physicists in Innsbruck have developed a protocol to pass quantum information between differently encoded building blocks of a future quantum computer, such as processors and memories. Scientists may use this protocol in the future to build a data bus for quantum computers. The researchers have published their work in the journal Nature Communications.

Future quantum computers will be able to solve problems where conventional computers fail today. We are still far away from any large-scale implementation,...

Im Focus: Wrinkles give heat a jolt in pillared graphene

Rice University researchers test 3-D carbon nanostructures' thermal transport abilities

Pillared graphene would transfer heat better if the theoretical material had a few asymmetric junctions that caused wrinkles, according to Rice University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

Antarctic landscape insights keep ice loss forecasts on the radar

20.11.2017 | Earth Sciences

Filling the gap: High-latitude volcanic eruptions also have global impact

20.11.2017 | Earth Sciences

Water world

20.11.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>